Literature DB >> 4173168

Family studies in systemic lupus erythematosus.

E T Leonhardt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4173168      PMCID: PMC1579519     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  8 in total

1.  Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis.

Authors:  T Feizi; R Naccarato; S Sherlock; D Doniach
Journal:  Clin Exp Immunol       Date:  1972-04       Impact factor: 4.330

2.  [Monozygotic twins with Klinefelter syndrome (concordant) and systemic lupus erythematodes (discordant)].

Authors:  B Schlegelberger; T Schlegelberger; J Kekow; W L Gross; W Grote
Journal:  Klin Wochenschr       Date:  1984-10-01

3.  Myositis in father and daughter.

Authors:  R M Lewkonia; P H Buxton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

4.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Long term prognosis of children born to lupus patients.

Authors:  A Murashima; T Fukazawa; M Hirashima; Y Takasaki; M Oonishi; S Niijima; Y Yamashiro; A Yamataka; T Miyano; H Hashimoto
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

6.  Multiple immunological abnormalities in a family.

Authors:  A M Mason; P L Golding
Journal:  J Clin Pathol       Date:  1971-11       Impact factor: 3.411

Review 7.  Recent advances in the immunopathogenesis of systemic lupus erythematosus.

Authors:  E J Bardana; B Pirofsky
Journal:  West J Med       Date:  1975-02

8.  The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

Authors:  A D Steinberg; S Baron; N Talal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.